Get started
Author

Magdalena Dutka

Observed names: Dutka, Magdalena, M. Dutka
ORCID: 0000-0001-8112-3974
Observed ORCID: 0000-0001-8112-3974
OpenAlex ID: A5067751111
Treatment of Graft-versus-Host Disease with Naturally Occurring T Regulatory Cells
2013 · Piotr Trzonkowski, Anna Dukat-Mazurek, et al. · BioDrugs · 41
PDF
Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG)
2009 · Ewa Lech-Maranda, Marek Seweryn, et al. · International Journal of Infectious Diseases · 40
PDF
Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study
2019 · Krzysztof Mądry, Karol Lis, et al. · Clinical Lymphoma Myeloma & Leukemia · 21
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients
2018 · Angelica Macauda, Eleonora Castelli, et al. · British Journal of Haematology · 17
PDF
The role of radiotherapy in the management of primary cardiac lymphoma a case report and the literature review
2018 · Natalia Cichowska-Cwalińska, Magdalena Dutka, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 13
Azacitidine Use After Allogeneic Stem Cell Transplantation—Results From the Polish Adult Leukemia Group
2016 · J. Drozd-Sokołowska, L. Gil, et al. · Transplantation Proceedings · 13
Anagrelide in essential thrombocythemia: Efficacy and long-term consequences in young patient population
2022 · Maria Bieniaszewska, Patryk Sobieralski, et al. · Leukemia Research · 12
PDF
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients
2021 · Angelica Macauda, Chiara Piredda, et al. · International Journal of Cancer · 12
BKV Related Hemorrhagic Cystitis—An Insight into Risk Factors and Later Complications—An Analysis on Behalf of Polish Adult Leukemia Group
2022 · Jarosław Dybko, Agnieszka Piekarska, et al. · Cancers · 10
PDF
Atypical chronic myeloid leukaemia: A case of an orphan disease—A multicenter report by the Polish Adult Leukemia Group
2018 · Joanna Drozd‐Sokołowska, Krzysztof Mądry, et al. · Hematological Oncology · 9
Patient-reported outcomes with belantamab mafodotin, pomalidomide, and dexamethasone versus bortezomib, pomalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-8): a phase 3, open-label, randomised controlled trial
2025 · Meletios A Dimopoulos, Meletios A Dimopoulos, et al. · The Lancet Haematology · 6
Azacitidine for relapse of acute myeloid leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation, multicenter PALG analysis
2021 · Joanna Drozd‐Sokołowska, Ewa Karakulska‐Prystupiuk, et al. · European Journal Of Haematology · 5
P-090 Infections and Immune Reconstitution in the Phase 3 CARTITUDE-4 Trial of Ciltacabtagene Autoleucel vs Standard Care in Patients with Lenalidomide-Refractory Multiple Myeloma (MM) and 1–3 Prior Lines
2024 · Niels van de Donk, Joaquín Martínez-Lopez, et al. · Clinical Lymphoma Myeloma & Leukemia · 4
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors
2022 · Michał Cezary Czarnogórski, Justyna Sakowska, et al. · Immunity & Ageing · 4
PDF
Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma
2026 · Krzysztof Jamroziak, Dominik Dytfeld, et al. · British Journal of Haematology · 3
PDF
Prognostic Impact of Copy Number Alterations’ Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy
2023 · Marta Libura, Karolina Karabin, et al. · Cancers · 3
PDF
Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation—A Multicenter Report by the Polish Myeloma Study Group
2024 · Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, et al. · Cancers · 2
PDF
P1535: Assessment of Colonization and Infection Epidemiology in Patients Undergoing Allogeneic Stem Cell Transplantation – a Prospective Multi-center Study of Polish Adult Leukemia Group (palg).
2023 · Agnieszka Pluta, Kinga Krawiec, et al. · HemaSphere · 2
A compelling case for central pathology review of multiparameter flow cytometry measurable residual disease results in Acute Myeloid Leukemia (AML) clinical trials: Data from the PALG-AML1/2016 multicenter randomized study
2025 · Agnieszka Wierzbowska, Anna Czyz, et al. · Blood · 1
Ciltacabtagene Autoleucel vs Standard of Care in Lenalidomide-Refractory Multiple Myeloma: Phase 3 CARTITUDE-4 Subgroup Analysis by Cytogenetic Risk
2024 · Roberto Mina, Binod Dhakal, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
MM-567 Ciltacabtagene Autoleucel vs Standard of Care in Lenalidomide-Refractory Multiple Myeloma: Phase 3 CARTITUDE-4 Subgroup Analysis by Cytogenetic Risk
2024 · Roberto Mina, Binod Dhakal, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Long-term allogeneic hematopoietic cells transplantation survivors proinflammatory cytokine profile compared to their respective donors and immunophenotype differences depending on GvHD history and infection status
2023 · Michał Cezary Czarnogórski, Mateusz Maziewski, et al. · Acta Haematologica Polonica · 1
PDF
POSTER: AML-585: The Prognostic Value of Day 14 Bone Marrow Blast Clearance Is Mutation-Dependent in Newly Diagnosed, Intensively Treated Acute Myeloid Leukemia
2026 · Zuzanna Nowicka-Kaszkowiak, Agnieszka Pluta, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-585: The Prognostic Value of Day 14 Bone Marrow Blast Clearance Is Mutation-Dependent in Newly Diagnosed, Intensively Treated Acute Myeloid Leukemia
2026 · Zuzanna Nowicka-Kaszkowiak, Agnieszka Pluta, et al. · Clinical Lymphoma Myeloma & Leukemia
Successful CAR-T cell administration in a patient with end stage renal impairment
2026 · Karolina Bełdzińska-Gądek, Monika Szarejko, et al. · Acta Haematologica Polonica
PDF
Works count: 50
Citation count: 219
H-index: 9
I10-index: 9
Year
Topic
Type